| Alpa Bharat Shah, MD | |
|
7455 W Washington Ave Ste 301, Las Vegas, NV 89128-4340 | |
| (877) 562-5227 | |
| (702) 938-9954 |
| Full Name | Alpa Bharat Shah |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 11 Years |
| Location | 7455 W Washington Ave Ste 301, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457779985 | NPI | - | NPPES |
| 1457779985 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 18829 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sunrise Hospital And Medical Center | Las vegas, NV | Hospital |
| Summerlin Hospital Medical Center | Las vegas, NV | Hospital |
| Henderson Hospital | Henderson, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Laboratory Medicine Consultants Ltd | 4183617533 | 27 |
| Laboratory Medicine Consultants Ltd | 4183617533 | 27 |
News Archive
Cerus Corporation announced today that its Phase 1 trial of red blood cells treated with the INTERCEPT Blood System met its primary endpoint, with preliminary analysis demonstrating that greater than 75 percent of treated cells continued to circulate 24 hours following transfusion. The INTERCEPT red blood cell system is a pathogen inactivation treatment the company is developing to protect against transmission of infectious diseases through red blood cell transfusions. An estimated 70 million units of red blood cells are transfused worldwide each year.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, is pleased to announce that its novel sodium channel blocker, CNV1014802 ('802), has been granted orphan-drug designation by the US Food and Drug Administration for the treatment of trigeminal neuralgia.
Injuries to the rotator cuff are treatable, but it is unclear which treatment option - surgery or nonsurgical treatments such as exercise or medication - is best, according to a new comparative effectiveness report published by HHS' Agency for Healthcare Research and Quality.
Severity of illness, history of stroke, and being divorced or widowed were independently predictive of delirium in hospitalized patients in Zambia, according to a study published in PLOS ONE.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
› Verified 7 days ago
| Entity Name | Laboratory Medicine Consultants Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083675169 PECOS PAC ID: 4183617533 Enrollment ID: O20040618000578 |
News Archive
Cerus Corporation announced today that its Phase 1 trial of red blood cells treated with the INTERCEPT Blood System met its primary endpoint, with preliminary analysis demonstrating that greater than 75 percent of treated cells continued to circulate 24 hours following transfusion. The INTERCEPT red blood cell system is a pathogen inactivation treatment the company is developing to protect against transmission of infectious diseases through red blood cell transfusions. An estimated 70 million units of red blood cells are transfused worldwide each year.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, is pleased to announce that its novel sodium channel blocker, CNV1014802 ('802), has been granted orphan-drug designation by the US Food and Drug Administration for the treatment of trigeminal neuralgia.
Injuries to the rotator cuff are treatable, but it is unclear which treatment option - surgery or nonsurgical treatments such as exercise or medication - is best, according to a new comparative effectiveness report published by HHS' Agency for Healthcare Research and Quality.
Severity of illness, history of stroke, and being divorced or widowed were independently predictive of delirium in hospitalized patients in Zambia, according to a study published in PLOS ONE.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alpa Bharat Shah, MD 11025 Rca Center Dr Ste 300, Palm Beach Gardens, FL 33410-4269 Ph: (561) 383-3820 | Alpa Bharat Shah, MD 7455 W Washington Ave Ste 301, Las Vegas, NV 89128-4340 Ph: (877) 562-5227 |
News Archive
Cerus Corporation announced today that its Phase 1 trial of red blood cells treated with the INTERCEPT Blood System met its primary endpoint, with preliminary analysis demonstrating that greater than 75 percent of treated cells continued to circulate 24 hours following transfusion. The INTERCEPT red blood cell system is a pathogen inactivation treatment the company is developing to protect against transmission of infectious diseases through red blood cell transfusions. An estimated 70 million units of red blood cells are transfused worldwide each year.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, is pleased to announce that its novel sodium channel blocker, CNV1014802 ('802), has been granted orphan-drug designation by the US Food and Drug Administration for the treatment of trigeminal neuralgia.
Injuries to the rotator cuff are treatable, but it is unclear which treatment option - surgery or nonsurgical treatments such as exercise or medication - is best, according to a new comparative effectiveness report published by HHS' Agency for Healthcare Research and Quality.
Severity of illness, history of stroke, and being divorced or widowed were independently predictive of delirium in hospitalized patients in Zambia, according to a study published in PLOS ONE.
Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.
› Verified 7 days ago
Mrs. June Durkee Sigman, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 7455 W Washington Ave Ste 301, Las Vegas, NV 89128 Phone: 877-562-5227 Fax: 702-732-2310 | |
Dr. Bert G. Dougherty, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3059 S Maryland Pkwy, 100, Las Vegas, NV 89109 Phone: 702-732-3441 Fax: 702-732-2310 | |
Dr. David Patrick Marmaduke, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3059 S Maryland Pkwy Ste 100, Las Vegas, NV 89109 Phone: 702-732-3441 Fax: 702-732-2310 | |
Narciss Mobini, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4230 Burnham Ave, Las Vegas, NV 89119 Phone: 702-733-7866 Fax: 702-792-1319 | |
Mr. Jonathan Howard Hughes, MD PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3059 S Maryland Pkwy Ste 100, Las Vegas, NV 89109 Phone: 702-732-3441 Fax: 702-732-2310 | |
Peter Aylward Scully, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 4230 Burnham Avenue, Las Vegas, NV 89119 Phone: 702-733-7866 Fax: 702-792-1319 | |
Jonathan Stuart Strauss, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4230 Burnham Ave, Las Vegas, NV 89119 Phone: 702-733-7866 Fax: 702-792-1319 |